share_log

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham重申對avadel pharmaceuticals的買入評級,維持22美元的價格目標。
Benzinga ·  2024/10/18 17:53

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

Needham分析師Ami Fadia重申對avadel pharmaceuticals(納斯達克:AVDL)的買入評級,維持22美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論